Abstract
Medulloblastoma and central nervous system primitive neuroectodermal tumors (CNS-PNET) are aggressive, poorly differentiated brain tumors with limited effective therapies. Using Sleeping Beauty (SB) transposon mutagenesis, we identified novel genetic drivers of medulloblastoma and CNS-PNET. Cross-species gene expression analyses classified SB-driven tumors into distinct medulloblastoma and CNS-PNET subgroups, indicating they resemble human Sonic hedgehog and group 3 and 4 medulloblastoma and CNS neuroblastoma with FOXR2 activation. This represents the first genetically induced mouse model of CNS-PNET and a rare model of group 3 and 4 medulloblastoma. We identified several putative proto-oncogenes including Arh-gap36, Megf10, and Foxr2. Genetic manipulation of these genes demonstrated a robust impact on tumorigenesis in vitro and in vivo. We also determined that FOXR2 interacts with N-MYC, increases C-MYC protein stability, and activates FAK/SRC signaling. Altogether, our study identified several promising therapeutic targets in medulloblastoma and CNS-PNET. Significance: A transposon-induced mouse model identifies several novel genetic drivers and potential therapeutic targets in medulloblastoma and CNS-PNET.
Original language | English (US) |
---|---|
Pages (from-to) | 905-917 |
Number of pages | 13 |
Journal | Cancer Research |
Volume | 79 |
Issue number | 5 |
DOIs | |
State | Published - Mar 1 2019 |
Bibliographical note
Publisher Copyright:© 2019 American Association for Cancer Research.
Fingerprint
Dive into the research topics of 'Sleeping beauty insertional mutagenesis reveals important genetic drivers of central nervous system embryonal tumors'. Together they form a unique fingerprint.Equipment
-
Leica MZ FL III Fluorescence Stereomicroscope
University Imaging CentersEquipment/facility: Equipment
-
University Imaging Centers
Mark A Sanders (Program Director) & Guillermo Marques (Scientific Director)
University Imaging CentersEquipment/facility: Facility